Monocyte/Macrophage Activation by Normal Bacteria and Bacterial Products: Implications for Altered Epithelial Function in Crohn’s Disease
Open Access
- 31 March 2001
- journal article
- research article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 158 (3), 1101-1109
- https://doi.org/10.1016/s0002-9440(10)64057-6
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Breakdown of tolerance to the intestinal bacterial flora in inflammatory bowel disease (IBD)Clinical and Experimental Immunology, 1995
- Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2)Gastroenterology, 1995
- Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.Gut, 1994
- Interleukin-10-deficient mice develop chronic enterocolitisCell, 1993
- Detection of mRNAs for macrophage products in inflammatory bowel disease by in situ hybridisation.Gut, 1992
- Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileumThe Lancet, 1991
- Double blind, placebo controlled trial of metronidazole in Crohn's disease.Gut, 1991
- Inflammatory Products of Commensal Bacteria and Gastro-Intestinal DisordersDigestive Diseases, 1990
- Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers.JCI Insight, 1989
- Isolation and functional characterization of human intestinal mucosal lymphoid cells.JCI Insight, 1977